Chemoinformaics analysis of (5Z,11Z,14Z,17Z)-ICOSA-5,11,14,17-TETRAENOIC ACID
| Molecular Weight | 304.474 | nRot | 14 |
| Heavy Atom Molecular Weight | 272.218 | nRig | 2 |
| Exact Molecular Weight | 304.24 | nRing | 0 |
| Solubility: LogS | -5.475 | nHRing | 0 |
| Solubility: LogP | 9.749 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 54 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 56.3414 |
| nHD | 1 | BPOL | 32.9706 |
| QED | 0.137 |
| Synth | 1.913 |
| Natural Product Likeliness | 0.394 |
| NR-PPAR-gamma | 0.983 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.007 |
| CACO-2 | -5.22 |
| MDCK | 0.00000885 |
| BBB | 0.003 |
| PPB | 0.980504 |
| VDSS | 1.039 |
| FU | 0.00497244 |
| CYP1A2-inh | 0.076 |
| CYP1A2-sub | 0.155 |
| CYP2c19-inh | 0.142 |
| CYP2c19-sub | 0.047 |
| CYP2c9-inh | 0.051 |
| CYP2c9-sub | 0.996 |
| CYP2d6-inh | 0.015 |
| CYP2d6-sub | 0.032 |
| CYP3a4-inh | 0.092 |
| CYP3a4-sub | 0.006 |
| CL | 2.935 |
| T12 | 0.389 |
| hERG | 0.186 |
| Ames | 0.004 |
| ROA | 0.009 |
| SkinSen | 0.934 |
| Carcinogencity | 0.031 |
| EI | 0.903 |
| Respiratory | 0.919 |
| NR-Aromatase | 0.076 |
| Antiviral | No |
| Prediction | 0.543563 |